|
Volumn 10, Issue 11, 2009, Pages 1025-
|
Predicting recurrence-free survival after surgery for GIST
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMATINIB;
PLACEBO;
ADJUVANT THERAPY;
CANCER RECURRENCE;
CANCER RELAPSE;
CANCER STAGING;
CANCER SURVIVAL;
DISEASE FREE SURVIVAL;
GASTROINTESTINAL STROMAL TUMOR;
GASTROINTESTINAL SURGERY;
HUMAN;
INDIVIDUALIZATION;
LETTER;
LIVER METASTASIS;
MITOSIS;
NOMOGRAM;
PREDICTION;
PRIORITY JOURNAL;
PROBABILITY;
PROGNOSIS;
RECURRENCE RISK;
RISK ASSESSMENT;
SCORING SYSTEM;
TREATMENT OUTCOME;
TUMOR LOCALIZATION;
TUMOR VOLUME;
ANTINEOPLASTIC AGENTS;
CHEMOTHERAPY, ADJUVANT;
DIGESTIVE SYSTEM SURGICAL PROCEDURES;
DISEASE-FREE SURVIVAL;
GASTROINTESTINAL STROMAL TUMORS;
HUMANS;
MITOTIC INDEX;
NEOPLASM INVASIVENESS;
NEOPLASM STAGING;
NOMOGRAMS;
PATIENT SELECTION;
PIPERAZINES;
PREDICTIVE VALUE OF TESTS;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
REPRODUCIBILITY OF RESULTS;
RISK ASSESSMENT;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 71249127202
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(09)70267-0 Document Type: Letter |
Times cited : (19)
|
References (5)
|